What is the recommended postoperative pain management regimen, including multimodal pharmacologic and non‑pharmacologic strategies?

Postoperative Pain Management

Implement a multimodal, opioid-sparing regimen combining acetaminophen, NSAIDs (or COX-2 inhibitors), regional analgesia or surgical site infiltration with local anesthetics, and dexamethasone as the foundation for all surgical patients unless specific contraindications exist 1, 2.

Core Pharmacologic Strategy

The evidence is unequivocal that multimodal analgesia targeting different pain pathways provides superior outcomes compared to opioid-centered approaches 1, 3. The 2026 ASA guidelines emphasize that systemic analgesic recommendations are consistent across all surgical procedures, with regional techniques being the variable component 1.

First-Line Systemic Agents (Start Pre- or Intraoperatively)

• Acetaminophen: Administer routinely unless contraindicated; continue postoperatively 2, 4
• NSAIDs or COX-2 inhibitors: Use routinely as a cornerstone agent; provides modest 12-24 hour pain reduction and significant opioid-sparing effects 2, 5, 3
• Dexamethasone: Delivers dual analgesic and antiemetic benefits; include as standard 4, 3

These three agents form the non-negotiable foundation and should be continued postoperatively, not just given as single doses 4.

Regional Analgesia and Local Infiltration

Regional techniques demonstrate the most robust evidence for reducing both acute postoperative pain and chronic postsurgical pain 3. The 2026 ASA guidelines provide procedure-specific recommendations 1:

Recommended Applications

• Fascial plane blocks: Strongly recommended for adults undergoing minimally invasive abdominal procedures and children undergoing open cardiac/thoracic surgeries 1
• Continuous infiltration catheters: Probably recommended for laparotomy, cesarean section, and lumbotomy when epidural analgesia is not used 2
• Surgical site infiltration: Use local anesthetics (ropivacaine preferred for neurosurgery) for wound infiltration 5, 4

Critical Safety Consideration

Do not exceed maximum toxic doses of local anesthetics, particularly with peri-prosthetic infiltrations or when combining wound infiltration with perineural catheters 2. Maximum first-injection doses for ASA 1 adults:

• Lidocaine with epinephrine: 7 mg/kg
• Ropivacaine/Levobupivacaine: 3 mg/kg
• Mepivacaine: 5 mg/kg

Avoid intra-articular catheters due to direct chondrocyte toxicity 2.

Adjunctive Pharmacologic Agents (Selective Use)

Use these when basic multimodal analgesia is insufficient or for specific surgical contexts:

Ketamine

• Intraoperative use only: Provides estimated 30% reduction in chronic pain at 3 months (low evidence) 2
• Do not continue postoperatively—increases hallucination risk without additional analgesic benefit 2
• Particularly beneficial for major intracranial procedures to modulate central sensitization 5

IV Lidocaine Infusion

• First-line option when additional analgesia needed 4
• Unique advantage in accelerating gastrointestinal recovery 3

Gabapentinoids

• Not recommended for routine preoperative use 2
• May reduce opioid consumption but increase dizziness and somnolence 5
• Reserve for selective cases with careful consideration of sedation risk in ambulatory settings 4

Alpha-2 Agonists (Dexmedetomidine, Clonidine)

• Consistently prolong analgesia and reduce perioperative opioid requirements 3
• Monitor for sedation and hypotension, especially in ambulatory surgery 4

Magnesium

• Not currently recommended due to insufficient evidence 2

Opioid Use: Rescue Only

Opioids should only be used when needed on top of multimodal nonopioid prophylaxis 4. When required:

• Use non-depot formulations only
• Titrate to effect in the post-anesthesia care unit
• Continue for a few days maximum as needed 4
• Recognize that 10-20% of cases will require adjustment beyond the basic guideline due to contraindications, more extensive procedures, or patient risk factors for severe pain 4

Non-Pharmacologic Interventions

While evidence is more limited and heterogeneous, consider adjunctive use of 5, 6:

• Cognitive-behavioral therapy
• Physical rehabilitation and early mobilization
• Transcutaneous electrical nerve stimulation (TENS)
• Acupuncture
• Digital therapeutics and wearable monitoring platforms

These show particular promise for longer-term or neuropathic symptoms but should not replace pharmacologic multimodal strategies 5.

Common Pitfalls to Avoid

1. Delaying multimodal agents until postoperative period: Start acetaminophen, NSAIDs, and dexamethasone pre- or intraoperatively 4
2. Single-dose mentality: Continue acetaminophen and NSAIDs postoperatively, not just intraoperatively 4
3. Opioid-first approach: Reserve opioids as rescue after establishing multimodal foundation 4, 3
4. Ignoring local anesthetic toxicity limits: Particularly dangerous with combined techniques 2
5. Routine gabapentinoid prophylaxis: Evidence does not support systematic preoperative use 2
6. Continuing ketamine postoperatively: Increases adverse effects without benefit 2

Algorithm for 10-20% Requiring Enhanced Analgesia

When the basic multimodal regimen is insufficient 4:

1. First, add: Nerve blocks, fascial plane blocks, or continuous infiltration catheters
2. Second, consider: IV lidocaine infusion
3. Third, selectively add: Gabapentinoids, dexmedetomidine, or ketamine (intraoperatively only), weighing sedation/hypotension risks
4. Finally, rescue with: Titrated short-acting opioids as needed

This hierarchical approach prioritizes the most effective opioid-sparing strategies with the best safety profiles 4, 3.